Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer Associated Thrombosis: What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO (a Retrospective Multicenter Study)

NCT04846556 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.

NCT NCT04846556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04846556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer Associated Thrombosis: What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO (a Retrospective Multicenter Study)
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Phase
Observational
Overall status
Completed
Start date
April 1, 2022
Completion date
June 30, 2022
Enrollment
300 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, venous thromboembolism